COUR PHARMACEUTICALS DEVELOPMENT
Cour Pharmaceuticals Development Co Inc operates in the pharmaceutical sector. Cour Pharmaceuticals Development Co Inc was founded in 2012 and is based in Elmhurst, Illinois.
COUR PHARMACEUTICALS DEVELOPMENT
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Skokie, Illinois, United States
Country:
United States
Website Url:
http://www.courpharma.com
Total Employee:
11+
Status:
Active
Contact:
8885512687
Email Addresses:
[email protected]
Total Funding:
30.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Investors List
Alpha Wave Ventures
Alpha Wave Ventures investment in Venture Round - Cour Pharmaceuticals Development
Official Site Inspections
http://www.courpharma.com
- Host name: 187.206.196.104.bc.googleusercontent.com
- IP address: 104.196.206.187
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Cour Pharmaceuticals Development"
Our Company - COUR Pharmaceuticals
This approach does not address the underlying cause of immune-related disease. Scientists in immunology have posited that the gold standard for treating immune-related disease is tolerance โ getting the body to recognize and tolerate the โฆSee details»
Leadership - COUR Pharmaceuticals
Leadership. Bringing together extensive expertise in clinical development, scientific research, manufacturing and business, COURโs leadership team embodies the companyโs mission to deliver life-changing therapies designed โฆSee details»
Cour Company Profile 2024: Valuation, Funding & Investors
Cour General Information Description. Developer of an immune-modifying platform intended to achieve antigen-specific tolerance for immune-mediated disease. The company's platform โฆSee details»
Cour Pharmaceuticals Development Co., Inc. | LinkedIn
Cour Pharmaceuticals Development Co., Inc. Pharmaceutical Manufacturing Skokie, Illinois 4,527 followers First-in-class therapies designed to reprogram the immune systemSee details»
COUR Pharmaceuticals Announces Leadership Transition for โฆ
Aug 1, 2024 COUR Pharmaceuticals, a clinical-stage biotechnology company developing ๏ฌrst-in-class, disease-modifying therapies designed to induce antigen-speci๏ฌc tolerance for โฆSee details»
Cour Pharma - Company Profile - Tracxn
Dec 9, 2024 Email ID: *****@courpharma.com; Key Metrics. Total Funding. $135M in 6 rounds. Latest Funding Round. Series A, Jan 30, 2024, $105M. Investors. Roche & 6 more. Ranked. โฆSee details»
Cour Pharmaceuticals - Overview, News & Similar companies
Feb 16, 2024 www.courpharma.com. Revenue <$5 Million. Industry Drug Manufacturing & Research Pharmaceuticals Healthcare . Recent News & Media. COUR Pharmaceuticals โฆSee details»
Cour Pharmaceuticals Development - Crunchbase
Organization. Cour Pharmaceuticals Development . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email โฆSee details»
Board of Directors - COUR Pharmaceuticals
Tim Walbert. Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, AmgenSee details»
COUR Pharmaceuticals Secures $105 Million in Series A Financing โฆ
Jan 30, 2024 Funds will be used to support the advancement of COURโs Myasthenia Gravis (MG) and Type 1 Diabetes (T1D) product candidates into Phase 2a clinical trialsParticipating โฆSee details»
Cour Pharmaceuticals Development Co., Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cour Pharmaceuticals Development Co., Inc. of Skokie, IL. Get the latest business insights from โฆSee details»
COUR Pharmaceuticals Secures $105 Million in Series A
Jan 30, 2024 For more information, please visit www.courpharma.com. About Lumira Ventures: Founded in 2007, Lumira Ventures is a multi-stage life sciences investment firm with offices in โฆSee details»
Cour gets $105M, pharma help to โreprogramโ autoimmune disease
Jan 30, 2024 Dive Insight: Typically, biotech startups are far from clinical testing when they raise their first venture funding. But Cour, which was spun out around research at Northwestern โฆSee details»
COUR Pharmaceuticals Announces Leadership Transition for
Aug 1, 2024 Founder John J. Puisis to transition CEO role to current COO Dannielle Appelhans. Mr. Puisis to remain on COUR Board of Directors. CHICAGO, Aug. 01, 2024 (GLOBE โฆSee details»
Contact Us - COUR Pharmaceuticals
Connect with us. [email protected]. *protected email*. The Latest COUR Pharmaceuticals Enters Collaboration and Licensing Agreement with Genentech to Develop and Commercialize โฆSee details»
COUR Pharmaceuticals Announces $30M Financing Led by Alpha โฆ
Sep 7, 2022 For more information, please visit www.courpharma.com. About Alpha Wave Global Alpha Wave is a global investment company with offices in New York, Miami , London , Abu โฆSee details»
Careers - COUR Pharmaceuticals
Since joining Cour as an intellectual property and business analyst, each day has brought about multiple opportunities to learn new skills and to overcome challenges in a collegial, inclusive, โฆSee details»
Cour Pharmaceuticals Development Company, Inc
Cour Pharmaceuticals Development Company, Inc. 101 likes. We are a group of dedicated scientific, medical, and business professionals who are driven to...See details»
Our Technology - COUR Pharmaceuticals
In Our Pipeline. We are rapidly advancing our pipeline of first-in-class therapies for immune-mediated diseases. Our novel nanoparticle platform is designed to induce disease-specific โฆSee details»